한글목차

호중구감소증 치료 동향 및 전망

세계 호중구감소증 치료 시장의 미래는 병원 약국, 소매 약국 및 온라인 약국 시장에 기회가 있고 유망해 보입니다. 세계 호중구감소증 치료 시장은 2024년부터 2030년까지 6.0%의 CAGR로 2030년까지 약 203억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 암 진단의 급증, 연구개발을 통한 선구적인 호중구감소증 치료법에 대한 업계의 노력 확대, 류마티스 관절염, 루푸스, 크론병과 같은 자가면역질환과 패혈증, 결핵, 간염과 같은 감염성 질환의 빈도가 증가하고 있는 점입니다.

호중구감소증 치료 시장에 대한 인사이트

Lucintel은 집락자극인자가 예측 기간 동안 가장 높은 성장을 이룰 것으로 예상했습니다.

이 시장에서 병원 약국은 앞으로도 가장 큰 시장이 될 것입니다.

아시아태평양은 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

자주 묻는 질문

Q1. 호중구감소증 치료 시장 규모는 어느 정도입니까?

A1. 세계 호중구감소증 치료 시장은 2030년까지 약 203억 달러에 달할 것으로 예상됩니다.

Q2. 호중구감소증 치료 시장의 성장 전망은?

A2. 세계 호중구감소증 치료 시장은 2024년부터 2030년까지 6.0%의 CAGR로 성장할 것으로 예상됩니다.

Q3. 호중구감소증 치료 시장의 성장에 영향을 미치는 주요 요인은 무엇인가?

A3. 이 시장의 주요 촉진요인은 암 진단의 급증, 연구 개발을 통한 선구적인 호중구 감소증 치료에 대한 업계의 노력 확대, 류마티스 관절염, 루푸스, 크론병과 같은 자가 면역 질환과 패혈증, 결핵, 간염과 같은 감염성 질환의 빈도가 증가하고 있습니다.

Q4. 시장의 주요 부문은?

A4. 호중구감소증 치료 시장의 미래는 병원 약국, 소매 약국, 온라인 약국 시장에 기회가 있고 유망해 보입니다.

Q5. 시장의 주요 기업은?

A5. 주요 호중구감소증 치료 기업은 다음과 같습니다.

• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Spectrum Pharmaceuticals
• Beyondspring
• Coherus Biosciences
• Kyowa Kirin
• Cellerant Therapeutics
• Pfizer
• Amgen

Q6. 향후 가장 큰 시장 부문은?

A6. Lucintel은 집락자극인자가 예측 기간 동안 가장 높은 성장을 이룰 것으로 예상됩니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디인가?

A7. 아시아태평양은 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 호중구감소증 치료 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 호중구감소증 치료 시장 동향(2018-2023)과 예측(2024-2030)
• 치료별 세계의 호중구감소증 치료 시장
  • 집락자극인자
  • 항생제
  • 항진균제
  • 항바이러스제
• 유통 채널별 세계의 호중구감소증 치료 시장
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 호중구감소증 치료 시장
• 북미의 호중구감소증 치료 시장
• 유럽의 호중구감소증 치료 시장
• 아시아태평양의 호중구감소증 치료 시장
• 기타 지역의 호중구감소증 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 치료별 세계의 호중구감소증 치료 시장 성장 기회
  • 유통 채널별 세계의 호중구감소증 치료 시장 성장 기회
  • 지역별 세계의 호중구감소증 치료 시장 성장 기회
• 세계의 호중구감소증 치료 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 호중구감소증 치료 시장 능력 확대
  • 세계의 호중구감소증 치료 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Spectrum Pharmaceuticals
• Beyondspring
• Coherus Biosciences
• Kyowa Kirin
• Cellerant Therapeutics
• Pfizer
• Amgen

영문목차

Neutropenia Treatment Trends and Forecast

The ffuture of the global neutropenia treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global neutropenia treatment market is expected to reach an estimated $20.30 billion by 2030 with a CAGR of 6.0% from 2024 to 2030. The major drivers for this market are surge in cancer diagnoses, growing industry commitment to pioneering neutropenia therapies through research and development, and increasing frequency of autoimmune illnesses including rheumatoid arthritis, lupus, and Crohn's disease, as well as infections like sepsis, TB, and hepatitis.

A more than 150-page report is developed to help in your business decisions.

Neutropenia Treatment by Segment

The study includes a forecast for the global neutropenia treatment by treatment, distribution channel, and region.

Neutropenia Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Colony-Stimulating Factor
• Antibiotics
• Antifungals
• Antivirals

Neutropenia Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Onlne Pharmacies

Neutropenia Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neutropenia Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neutropenia treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neutropenia treatment companies profiled in this report include-

• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Spectrum Pharmaceuticals
• Beyondspring
• Coherus Biosciences
• Kyowa Kirin
• Cellerant Therapeutics
• Pfizer
• Amgen

Neutropenia Treatment Market Insights

Lucintel forecasts that colony-stimulating factor is expected to witness highest growth over the forecast period.

Within this market, hospital pharmacies will remain the largest segment.

APAC is expected to witness highest growth over the forecast period.

Features of the Global Neutropenia Treatment Market

Market Size Estimates: Neutropenia treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neutropenia treatment market size by treatment, distribution channel, and region in terms of value ($B).

Regional Analysis: Neutropenia treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment, distribution channel, and regions for the neutropenia treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neutropenia treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the neutropenia treatment market size?

Answer: The global neutropenia treatment market is expected to reach an estimated $20.30 billion by 2030.

Q.2 What is the growth forecast for neutropenia treatment market?

Answer: The global neutropenia treatment market is expected to grow with a CAGR of 6.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the neutropenia treatment market?

Answer: The major drivers for this market are surge in cancer diagnoses, growing industry commitment to pioneering neutropenia therapies through research and development, and increasing frequency of autoimmune illnesses including rheumatoid arthritis, lupus, and Crohn's disease, as well as infections like sepsis, TB, and hepatitis.

Q4. What are the major segments for neutropenia treatment market?

Answer: The future of the neutropenia treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key neutropenia treatment market companies?

Answer: Some of the key neutropenia treatment companies are as follows.

• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Spectrum Pharmaceuticals
• Beyondspring
• Coherus Biosciences
• Kyowa Kirin
• Cellerant Therapeutics
• Pfizer
• Amgen

Q6. Which neutropenia treatment market segment will be the largest in future?

Answer: Lucintel forecasts that colony-stimulating factor is expected to witness highest growth over the forecast period.

Q7. In neutropenia treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neutropenia treatment market by treatment (colony-stimulating factor, antibiotics, antifungals, and antivirals), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neutropenia Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Neutropenia Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Neutropenia Treatment Market by Treatment
  • 3.3.1: Colony-Stimulating Factor
  • 3.3.2: Antibiotics
  • 3.3.3: Antifungals
  • 3.3.4: Antivirals
• 3.4: Global Neutropenia Treatment Market by Distribution Channel
  • 3.4.1: Hospital Pharmacies
  • 3.4.2: Retail Pharmacies
  • 3.4.3: Onlne Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Neutropenia Treatment Market by Region
• 4.2: North American Neutropenia Treatment Market
  • 4.2.2: North American Neutropenia Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Onlne Pharmacies
• 4.3: European Neutropenia Treatment Market
  • 4.3.1: European Neutropenia Treatment Market by Treatment: Colony-Stimulating Factor, Antibiotics, Antifungals, and Antivirals
  • 4.3.2: European Neutropenia Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Onlne Pharmacies
• 4.4: APAC Neutropenia Treatment Market
  • 4.4.1: APAC Neutropenia Treatment Market by Treatment: Colony-Stimulating Factor, Antibiotics, Antifungals, and Antivirals
  • 4.4.2: APAC Neutropenia Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Onlne Pharmacies
• 4.5: ROW Neutropenia Treatment Market
  • 4.5.1: ROW Neutropenia Treatment Market by Treatment: Colony-Stimulating Factor, Antibiotics, Antifungals, and Antivirals
  • 4.5.2: ROW Neutropenia Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Onlne Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neutropenia Treatment Market by Treatment
  • 6.1.2: Growth Opportunities for the Global Neutropenia Treatment Market by Distribution Channel
  • 6.1.3: Growth Opportunities for the Global Neutropenia Treatment Market by Region
• 6.2: Emerging Trends in the Global Neutropenia Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neutropenia Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neutropenia Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Teva Pharmaceutical Industries
• 7.2: Novartis
• 7.3: Mylan
• 7.4: Spectrum Pharmaceuticals
• 7.5: Beyondspring
• 7.6: Coherus Biosciences
• 7.7: Kyowa Kirin
• 7.8: Cellerant Therapeutics
• 7.9: Pfizer
• 7.10: Amgen